Case StudyBuilding Cell Signaling Technology’s commercial leadership since 2023

Cell Signaling Technology, a family-owned supplier of antibodies and research tools, is extending its reach beyond research labs to pharmaceutical manufacturing.

What began in 2023 with the appointment of its EMEA commercial leader has become an ongoing partnership, with strategic hires to support CST's expansion into new markets.

The first appointmentCommercial leadership for EMEA

Cell Signaling Technology (CST) is a private, family-owned company, founded by scientists in 1999 and headquartered in Massachusetts. It develops antibodies and research tools used in scientific discovery and drug development.

In late 2023, Wenham Carter supported the appointment of CST’s General Manager, EMEA, who has since been promoted to SVP Global Sales as well. The role leads the management and growth of CST’s operations across the region, including market-specific sales strategies, deeper customer engagement and entry into new territories.

That appointment was the start of a continuing relationship focused on supporting CST’s growth and strategic priorities. Wenham Carter has also supported further commercial appointments within CST’s account management function.

The growth strategySelling to a new kind of customer

Having traditionally sold to research organisations, CST is now expanding into large pharmaceutical companies and manufacturing, with products developed for use in production.

In 2026, that strategy shaped two further appointments. Rather than replace its Distributor Manager for Europe like for like, CST made the role more senior and widened it to cover EMEA. The new Senior Distributor Manager, EMEA, needed to be highly effective at managing distributor relationships across the region.

A Global Strategic Account Director will focus on a small number of strategically important pharmaceutical, biotechnology, CRO and CDMO customers, coordinating global account strategy with regional execution.

The latest searchGlobal account experience with hands-on ownership

The Global Strategic Account Director role called for someone who could shape global account strategy, bring regional teams along through influence, and own customer relationships directly.

Many candidates had managed major accounts in one region but had not owned strategy internationally. Others had the seniority but no longer wanted a hands-on role. Wenham Carter searched across research tools, biopharma services and the CRO and CDMO sector, looking for evidence of global account planning, complex contract negotiation and senior stakeholder influence rather than relying on job titles.

The person appointed brings more than 15 years of international commercial experience across pharma, biotechnology and CDMO organisations, including antibody development, bioprocessing and GMP manufacturing, which matches the customers CST is now pursuing.

People The Right People

Continue the conversation with the people who know this market, the businesses shaping it and the minds moving it forward.

Meet more of the team

Markets Explore markets beyond the obvious

We organise our expertise around dynamic, global market ecosystems - rather than traditional industry silos – to see and seek connections others cannot.

Markets

Partner with us FIND the minds that will move your market.

Whether you need a CEO, a team rebuild, or a strategic introduction, we’re here to help. Our networks, experience and approach put the right connections within reach.

Markets We operate where innovation happens

From in-orbit to in-vivo, we connect the right minds to move markets forward.

What expertise do you need?

Forces Navigating the dynamics of disruption

We track the forces rippling across industries and economies, spotting the first signs of what’s next so you are ready to act.

What's driving change in your business?

Solutions Helping you get ahead

We understand where you’re going and help you get there one person, team, partnership, or investment at a time.

What would help you go further?
Secret Link